Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Outlook 2022

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Outlook 2022

Table of Contents
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (Above or equal to 65)
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027
1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027
1.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
3.5.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.6.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.7.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2016-2021)
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 MSD
6.1.1 MSD Corporation Information
6.1.2 MSD Description and Business Overview
6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 MSD Recent Developments/Updates
6.2 Sanofipasteur
6.2.1 Sanofipasteur Corporation Information
6.2.2 Sanofipasteur Description and Business Overview
6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Sanofipasteur Recent Developments/Updates
6.3 CDIBP
6.3.1 CDIBP Corporation Information
6.3.2 CDIBP Description and Business Overview
6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 CDIBP Recent Developments/Updates
7 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
7.4 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
8.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers
9 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Growth Drivers
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
9.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
10 Global Market Forecast
10.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2022-2027)
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2022-2027)
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Comparison by Application (2021-2027)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Covered in This Study
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) of Key Manufacturers (2016-2021)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 19. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 23. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 27. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 31. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 35. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2016-2021)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2021)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2016-2021)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2016-2021)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2016-2021)
Table 47. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2016-2021)
Table 48. MSD Corporation Information
Table 49. MSD Description and Business Overview
Table 50. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 51. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 52. MSD Recent Developments/Updates
Table 53. Sanofipasteur Corporation Information
Table 54. Sanofipasteur Description and Business Overview
Table 55. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 56. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 57. Sanofipasteur Recent Developments/Updates
Table 58. CDIBP Corporation Information
Table 59. CDIBP Description and Business Overview
Table 60. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 61. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 62. CDIBP Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 66. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 67. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 68. 23-Valent Pneumococcal Polysaccharide Vaccine Growth Drivers
Table 69. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 70. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 71. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027) & (K Dose)
Table 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027) & (K Dose)
Table 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2022-2027) & (K Dose)
Table 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 81. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2020 & 2027
Figure 6. For Children (2-10)
Figure 7. For Person (10-64)
Figure 8. For The Old (Above or equal to 65)
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027 (K Dose)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2020
Figure 16. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020
Figure 21. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2016-2021)
Figure 44. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2016-2021)
Figure 45. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2020
Figure 46. Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2016-2021)
Figure 47. Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2020
Figure 48. Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 49. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 50. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

2023-2031 Report on Global Avian Influenza Vaccines Market by Player, Region, Type, Application and Sales Channel

Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 87

This report studies the Avian Influenza Vaccines market, covering market size for segment by type (Type H5, Type H9, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, CEVA, Zoetis, Elanco (Lohmann), Merck Animal Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Avian Influenza ......

2023-2031 Report on Global Avian Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Avian Influenza Vaccine market, covering market size for segment by type (H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, QYH Biotech, DHN, HVRI, CEVA, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market f......

Global Pneumococcal Polysaccharide Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 22-Aug-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Pneumococcal Polysaccharide Vaccine market: According to our latest research, the global Pneumococcal Polysaccharide Vaccine market looks promising in the next 5 years. As of 2022, the global Pneumococcal Polysaccharide Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and com......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 03-Aug-2023        Price: US 3260 Onwards        Pages: 121

The 23-Valent Pneumococcal Polysaccharide Vaccine market revenue was 2268.96 Million USD in 2022, and will reach 3932.11 Million USD in 2028, with a CAGR of 9.6% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the 23-Valent Pneumococcal Polysaccharide Vaccine industry, and breaks down according to the type, application, and consumption area of 23-Valent Pneumococcal Polysaccharide Vaccine. The report also introduces players in......

Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

Published: 01-Jul-2023        Price: US 2450 Onwards        Pages: 280

Executive Summary Azoth Analytics has released a research report titled "Global Seasonal Influenza Vaccine Market (2023 Edition)" which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine -IIV, Live Attenuated Influenza Vaccine - LAIV), Valency (Quadrivalent, Trivalent), Age Group (Pediatrics, Adults, Elderly) and By Distribution Channel (Hospitals, Pharmacies, Government Supp......

Global Japanese Encephalitis Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 97

The Japanese Encephalitis Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Japanese Encephalitis Vaccine industry, and breaks down according to the type, application, and consumption area of Japanese Encephalitis Vaccine. The report also introduces players in the industry from the perspective of the industry chain an......

Global Meningococcal Conjugate Market Insights, Forecast to 2029

Published: 16-Jun-2023        Price: US 4900 Onwards        Pages: 114

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. Market Analysis and Insights: Global Meningococcal Conjugate Market The global Meningococcal Conjugate market is projected to grow from US$ million in 2023 to ......

Global Encephalitis Vaccination Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 15-Jun-2023        Price: US 3260 Onwards        Pages: 118

The Encephalitis Vaccination market revenue was 52963.61 Million USD in 2022, and will reach 65320.29 Million USD in 2028, with a CAGR of 3.56% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Encephalitis Vaccination industry, and breaks down according to the type, application, and consumption area of Encephalitis Vaccination. The report also introduces players in the industry from the perspective of the industry chain and......

Global Encephalitis Vaccine Market Insights, Forecast to 2029

Published: 31-May-2023        Price: US 4900 Onwards        Pages: 113

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus. The global Encephalitis Vaccine market is projected to grow from US$ 1374.4 million in 2023 to US$ 1905......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs